CV Sciences (CVSI) Property, Plant & Equipment (Net) Growth (3y) (2016 - 2026)
CV Sciences (CVSI) Property, Plant & Equipment (Net) Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | 5.84% |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | -11.73% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | 7.65% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 0.86% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 27.15% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | -6.48% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 11.32% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 11.90% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 28.35% |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | -11.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.29% |
| Mar 31, 2026 | -13.93% |
| Dec 31, 2025 | -15.74% |
| Sep 30, 2025 | -18.09% |
| Jun 30, 2025 | -19.58% |
| Mar 31, 2025 | -30.85% |
| Dec 31, 2024 | -38.52% |
| Sep 30, 2024 | -38.90% |
| Jun 30, 2024 | -35.60% |
| Mar 31, 2024 | -50.86% |
| Dec 31, 2023 | -49.12% |
| Sep 30, 2023 | -49.49% |
| Jun 30, 2023 | -46.82% |
| Mar 31, 2023 | -48.70% |
| Dec 31, 2022 | -45.82% |
| Sep 30, 2022 | -43.14% |
| Jun 30, 2022 | -39.98% |
| Mar 31, 2022 | -26.12% |
| Dec 31, 2021 | -15.48% |
| Sep 30, 2021 | -0.16% |